File Download

There are no files associated with this item.

  • Find it @ UNIST can give you direct access to the published full text of this article. (UNISTARs only)
Related Researcher

채영찬

Chae, Young Chan
Cancer Translational Research Lab.
Read More

Views & Downloads

Detailed Information

Cited time in webofscience Cited time in scopus
Metadata Downloads

Mitochondrial HSP90 Accumulation Promotes Vascular Remodeling in Pulmonary Arterial Hypertension

Author(s)
Boucherat, OlivierPeterlini, ThibautBourgeois, AliceNadeau, ValerieBreuils-Bonnet, SandraBoilet-Molez, StephaniePotus, FrancoisMeloche, JolyaneChabot, SophieLambert, CarolineTremblay, EveChae, Young ChanAltieri, Dario CSutendra, GopinathMichelakis, Evangelos DPaulin, RoxaneProvencher, SteeveBonnet, Sebastien
Issued Date
2018-07
DOI
10.1164/rccm.201708-1751OC
URI
https://scholarworks.unist.ac.kr/handle/201301/23806
Fulltext
https://www.atsjournals.org/doi/10.1164/rccm.201708-1751OC
Citation
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, v.198, no.1, pp.90 - 103
Abstract
Rationale: Pulmonary arterial hypertension (PAH) is a vascular remodeling disease with a poor prognosis and limited therapeutic option. Although the mechanisms contributing to vascular remodeling in PAH are still unclear, several features, including hyper-proliferation and resistance to apoptosis of pulmonary artery smooth muscle cells (PASMCs), have led to the emergence of the cancer-like concept. The molecular chaperone heat shock protein 90 (HSP90) is directly associated with malignant growth and proliferation under stress conditions. In addition to be highly expressed in the cytosol, HSP90 exists in a subcellular pool compartmentalized in the mitochondria (mtHSP90) of tumor cells, but not in normal cells, where it promotes cell survival. Objectives: We hypothesized that mtHSP90 in PAH-PASMCs represents a protective mechanism against stress promoting their proliferation and resistance to apoptosis. Measurements and Main Results: We demonstrated that in response to stress HSP90 preferentially accumulates in PAH-PASMC mitochondria (dual immunostaining, immunoblot and immunogold electron microscopy) to ensure cell survival by preserving mitochondrial DNA integrity and bioenergetics functions (Seahorse). Whereas cytosolic HSP90 inhibition displays a lack of absolute specificity for PAH-PASMCs, Gamitrinib, a specific mtHSP90 inhibitor decreased mitochondrial DNA content and repair capacity and bioenergetics functions, thus repressing PAH-PASMC proliferation (Ki67 labeling) and resistance to apoptosis (Annexin V assay) without affecting control cells. In vivo, Gamitrinib improves PAH in two experimental rat models (monocrotaline and Fawn-Hooded rat). Conclusions: Our data show for the first time that accumulation of mtHSP90 is a feature of PAH-PASMCs and key regulator of mitochondrial homeostasis contributing to vascular remodeling in PAH.
Publisher
AMER THORACIC SOC
ISSN
1073-449X
Keyword (Author)
cell metabolismcancervascular smooth muscle cellsproliferationapoptosis
Keyword
DNA POLYMERASE-GAMMAPROSTATE-CANCERRIGHT VENTRICLEDRUG DESIGNAPOPTOSISCELLSDAMAGEGROWTHDICHLOROACETATETUMORIGENESIS

qrcode

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.